Status:

COMPLETED

Antibiotherapy During Therapeutic Hypothermia to Prevent Infectious Complications

Lead Sponsor:

University Hospital, Limoges

Conditions:

Ventilator-associated Pneumonia

Cardiac Arrests With Shockable Rhythm

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Mild therapeutic hypothermia is currently recommended in management of cardiac arrests with shockable rhythm. In mechanically ventilated patients who were resuscitated after out-of-hospital cardiac ar...

Detailed Description

Multicenter add-on randomized controlled double-blind trial assessing the efficacy of preventive antibiotics amoxicillin-clavulanic acid vs placebo to prevent occurrence of early VAP after out-of-hosp...

Eligibility Criteria

Inclusion

  • Older than 18 years-old, intubated and mechanically ventilated after out-of-hospital resuscitated cardiac arrest secondary to shockable rhythm
  • Hospitalized in an ICU
  • Mild therapeutic hypothermia procedure (32° to 35°C) scheduled (24 to 36 hours)
  • Delay from ROSC to randomisation \< 6 hours
  • Consent from family members or emergency consent

Exclusion

  • Pregnancy
  • Out-of-hospital cardiac arrest secondary to non shockable rhythm and In-hospital cardiac arrest
  • Need for cardiac support by cardiopulmonary bypass
  • Ongoing antibiotic therapy or during the week before
  • Ongoing or concomitant pneumonia
  • Known chronic colonization with MRB
  • Hypersensitivity to the active substances, to any of the penicillins or to any of the excipients.
  • History of a severe immediate hypersensitivity reaction (e.g. anaphylaxis) to another beta-lactam agent (e.g. a cephalosporin, carbapenem or monobactam).
  • History of jaundice/hepatic impairment due to amoxicillin/clavulanic acid, according to the latest version of the SmPC.
  • Previous lung disease
  • Predictable decision of early care limitation
  • Patient under guardianship or curatorship
  • Moribund patient
  • Participation to another trial within 30 days

Key Trial Info

Start Date :

August 18 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 14 2017

Estimated Enrollment :

197 Patients enrolled

Trial Details

Trial ID

NCT02186951

Start Date

August 18 2014

End Date

September 14 2017

Last Update

March 18 2020

Active Locations (16)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (16 locations)

1

CH Angouleme - Service de Réanimation

Angoulême, Saint Michel, France, 16470

2

CH Argenteuil - Service de Réanimation

Argenteuil, France, 95107

3

CH Brive La Gaillarde - Service de Réanimation

Brive-la-Gaillarde, France, 19100

4

CHU Dijon - Serve de Réanimation

Dijon, France, 21079